4.7 Article

Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles

Related references

Note: Only part of the references are listed.
Article Medical Laboratory Technology

SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections

Selena Mimmi et al.

Summary: In this pilot study, researchers describe a method to characterize the exosome-associated microRNA (exo-miRNA) signature in ACE2-positive and ACE2-negative exosomal populations. The researchers used a sorting protocol with recombinant biotin-conjugated SARS-CoV-2 spike protein to isolate exosomes from plasma samples of six patients. Differential expression of several miRNAs was identified between ExoACE2 and non-ExoACE2.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Article Oncology

A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression

Theophilos Tzaridis et al.

Summary: Evaluation of serum-derived extracellular vesicles (EVs) from glioblastoma patients reveals that the upregulation of CD29, CD44, CD81, C1QA, and histone H3 in serum EVs correlates with tumor progression, suggesting their potential as biomarkers.

INTERNATIONAL JOURNAL OF CANCER (2023)

Review Chemistry, Multidisciplinary

Digging the intercellular crosstalk via extracellular vesicles: May exosomes be the drug delivery solution for target glioblastoma?

Ana Macedo-Pereira et al.

Summary: This review summarizes the interplay between glioblastoma and exosomes, highlighting their role in the tumor microenvironment and their potential for non-invasive diagnoses and therapeutic approaches.

JOURNAL OF CONTROLLED RELEASE (2023)

Review Cell Biology

Context-specific regulation of extracellular vesicle biogenesis and cargo selection

Andrew C. C. Dixson et al.

Summary: Cells communicate with each other by secreting molecules into the extracellular space, and the selection of these molecules for secretion has been a long-standing question in the field. Recently, extracellular vesicles (EVs) have been recognized as important mediators of intercellular communication, transporting various molecular components to recipient cells. Understanding the context-specific mechanisms of EV biogenesis and cargo sorting is crucial for deciphering the specificity of EV-mediated signaling.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)

Review Cell Biology

Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma

Hong Luo et al.

Summary: Exosomes play a crucial role in cell-to-cell communication by transporting DNA, RNA, bioactive proteins, glucose chains, and metabolites. They have great potential as targeted drug carriers, cancer vaccines, and noninvasive biomarkers. Being highly versatile, exosomes have advantages such as high drug loading capacity, adjustable drug release, enhanced permeation and retention effect, biodegradability, biocompatibility, and low toxicity. With the growing interest in exosome-based therapeutics, this review focuses on the potential use of exosomes in immunotherapy targeting tumor-associated macrophages (TAMs) in glioma, a challenging brain tumor. TAMs contribute to the immunosuppressive microenvironment and strongly influence glioma progression, making them an attractive therapeutic target. Exosomes can serve as both drug delivery vehicles and liquid biopsy biomarkers for TAMs-centered treatment. This review also summarizes recent investigations into the molecular signaling events by TAMs that promote glioma progression.

CELL DEATH & DISEASE (2023)

Article Oncology

Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer

Karin Ekstrom et al.

Summary: Lymphatic drainage exudate retrieved from breast cancer patients after surgery contains EVs that can be isolated using SEC isolation. The EVs have several cancer-related markers including CD24, CD29, CD44 and CD146, proteins of potential interest as biomarkers as well as to increase the understanding of the mechanisms of cancer biology.

BMC CANCER (2022)

Review Clinical Neurology

Serum neurofilament light in MS: The first true blood-based biomarker?

Simon Thebault et al.

Summary: This review highlights the potential role of serum neurofilament light chain (sNfL) as a promising blood-derived biomarker in the routine management of multiple sclerosis (MS) patients. Various studies have shown associations of sNfL levels with outcomes of interest, including inflammatory activity, progression, treatment response, and prediction/prognosis, supporting its potential as an objective, convenient, and cost-effective adjunct to clinical assessment. Future research is needed to further explore the limitations of sNfL and pave the way for other promising biomarkers for precision medicine in MS patients.

MULTIPLE SCLEROSIS JOURNAL (2022)

Article Neurosciences

CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis

Michael Mazzucco et al.

Summary: This study developed a novel method to identify central nervous system (CNS) endothelial derived extracellular vesicles (EV) in human blood samples, and found that the plasma concentration of CNS endothelial derived EV was significantly increased in patients with active multiple sclerosis (MS), suggesting that it may serve as a biomarker of blood-brain barrier permeability and active disease in MS.

FLUIDS AND BARRIERS OF THE CNS (2022)

Article Clinical Neurology

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

Pascal Benkert et al.

Summary: sNfL is a biomarker of neuronal damage used in monitoring disease activity in multiple sclerosis patients. This study established a reference database to correct for age and BMI, showing sNfL's potential in identifying individuals at risk for future disease activity. The results suggest that sNfL Z scores could predict acute and chronic disease activity in multiple sclerosis patients, with higher Z scores indicating increased risk.

LANCET NEUROLOGY (2022)

Review Biotechnology & Applied Microbiology

Therapeutically harnessing extracellular vesicles

Lesley Cheng et al.

Summary: The field of extracellular vesicle (EV) research has rapidly developed and is now recognized for its potential in the treatment and diagnosis of diseases. This article provides an overview of the characteristics and physiological functions of EVs, their association with diseases, and the strategies for their therapeutic exploitation.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Neurosciences

Extracellular Vesicles at CNS barriers: Mode of action

Eva-Maria Kraemer-Albers

Summary: EVs interact with the blood-brain barrier to facilitate communication between the brain and periphery. They can be released, act on, or cross the barrier, exerting wide-ranging effects on brain-periphery communication in both healthy and pathological states.

CURRENT OPINION IN NEUROBIOLOGY (2022)

Article Oncology

NetrinG1+ Cancer-Associated Fibroblasts Generate Unique Extracellular Vesicles that Support the Survival of Pancreatic Cancer Cells Under Nutritional Stress

Kristopher S. Raghavan et al.

Summary: It is projected that pancreatic cancer will become the second deadliest cancer in the United States in 5 years. Pancreatic ductal adenocarcinoma (PDAC) is characterized by a unique tumor microenvironment rich in cancer-associated fibroblasts (CAFs) and a dense extracellular matrix (ECM). These pathogenic CAF/ECM units lead to the collapse of local blood vessels, resulting in a nutrient-poor tumor microenvironment. PDAC cells are able to survive nutrient stress through support from CAF-secreted small extracellular vesicles (sEVs). The expression of NetrinG1 (NetG1) in CAFs and active Integrin ct5131 in multivesicular bodies are associated with poor patient survival. NetG1+ CAFs secrete sEVs that promote Akt-mediated survival in nutrient-deprived PDAC cells and protect them from apoptosis.

CANCER RESEARCH COMMUNICATIONS (2022)

Article Biochemical Research Methods

MPAPASS software enables stitched multiplex, multidimensional EV repertoire analysis and a standard framework for reporting bead-based assays

Joshua A. Welsh et al.

Summary: Extracellular vesicles (EVs) carry various types of proteins and nucleic acids, and can provide a retrospective snapshot of cell state through liquid biopsies. Multiplex assays for high-parameter EV protein detection are still being developed. To facilitate EV repertoire studies, we developed MPAPASS software for stitched multiplex analysis, EV database-compatible reporting, and visualization of EV repertoires.

CELL REPORTS METHODS (2022)

Review Cell Biology

Extracellular Vesicles in Neuroinflammation

Giulia Marostica et al.

Summary: Extracellular vesicles (EVs) are a diverse group of membrane-bound particles that play a crucial role in cell-cell communication, with different types such as exosomes, microvesicles, and apoptotic bodies. EVs in the central nervous system act as biomarkers and drug carriers, showing high heterogeneity between different types and subtypes.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Clinical Neurology

Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study

Ida Manna et al.

Summary: This study demonstrated the potential of exosomal miRNAs as biomarkers to differentiate between Parkinson's disease and Progressive Supranuclear Paralysis, with specific miRNAs like miR-21-3p, miR-22-3p, miR-223-5p, miR-425-5p, miR-21-3p, and miR-199a-5p showing promise in accurate discrimination. The classifier consisting of six exosomal miRNAs had high diagnostic sensitivity and specificity in distinguishing PSP from PD.

PARKINSONISM & RELATED DISORDERS (2021)

Article Clinical Neurology

Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes

Cheng Jiang et al.

Summary: The study demonstrates that measuring alpha-synuclein levels above 14 pg/mL in L1CAM-immunocaptured serum exosomes can robustly differentiate Parkinson's disease from other movement disorders. Furthermore, elevated levels of exosomal clusterin in individuals with 4-repeat tauopathies, combined with alpha-synuclein, improves the assay's performance in distinguishing Parkinson's disease from 4-repeat tauopathies. However, correction for the generic exosomal protein syntenin-1 did not consistently enhance the assay's performance.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

The potential of serum neurofilament as biomarker for multiple sclerosis

Stefan Bittner et al.

Summary: Blood-based serum neurofilament light chain (sNfL) is being investigated as a biomarker for prognosis and treatment response in multiple sclerosis patients. It reflects ongoing inflammatory-driven neuroaxonal damage and has the potential to guide individualized clinical decision-making.

BRAIN (2021)

Article Biochemical Research Methods

L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma

Maia Norman et al.

Summary: L1CAM, previously thought to be a marker for neuron-derived extracellular vesicles, has been shown to not be associated with extracellular vesicles in human plasma or cerebrospinal fluid, and is therefore not recommended for use in NDEV isolation protocols.

NATURE METHODS (2021)

Review Biochemistry & Molecular Biology

The role of extracellular vesicles in the physiological and pathological regulation of the blood-brain barrier

Sara Busatto et al.

Summary: Extracellular vesicles are biological nanoparticles secreted by cells that can transport bioactive substances, serving as both a potential source of diagnostic biomarkers and a promising class of nanovehicles for drug delivery. They play a crucial role in maintaining the blood-brain barrier under normal physiological and pathological conditions.

FASEB BIOADVANCES (2021)

Article Clinical Neurology

microRNA and exosome profiling in multiple sclerosis

Marcin P. Mycko et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Cell Biology

Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles

Aled Clayton et al.

JOURNAL OF EXTRACELLULAR VESICLES (2019)

Review Medicine, Research & Experimental

CD36 tango in cancer: signaling pathways and functions

Jingchun Wang et al.

THERANOSTICS (2019)

Review Oncology

The biology and role of CD44 in cancer progression: therapeutic implications

Chen Chen et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Review Cell Biology

Shedding light on the cell biology of extracellular vesicles

Guillaume van Niel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Review Biochemistry & Molecular Biology

The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas

Davide Schiffer et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Neurosciences

Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers

Servio H. Ramirez et al.

FLUIDS AND BARRIERS OF THE CNS (2018)

Article Biochemical Research Methods

EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

Jan Van Deun et al.

NATURE METHODS (2017)

Review Cardiac & Cardiovascular Systems

Methodological Guidelines to Study Extracellular Vesicles

Frank A. W. Coumans et al.

CIRCULATION RESEARCH (2017)

Review Clinical Neurology

Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers

Alexander G. Thompson et al.

NATURE REVIEWS NEUROLOGY (2016)

Article Cell Biology

A novel multiplex bead-based platform highlights the diversity of extracellular vesicles

Nina Koliha et al.

JOURNAL OF EXTRACELLULAR VESICLES (2016)

Article Cell & Tissue Engineering

Cancer Stem Cell-Specific Scavenger Receptor CD36 Drives Glioblastoma Progression

James S. Hale et al.

STEM CELLS (2014)

Article Biochemical Research Methods

Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins:: Trophic support for axons?

Eva-Maria Kraemer-Albers et al.

PROTEOMICS CLINICAL APPLICATIONS (2007)

Article Neurosciences

Exosomes are released by cultured cortical neurones

J Fauré et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2006)